EODData

FRA, 3EE0: KANCERA AB

30 Sep 2025
LAST:

0.0011

CHANGE:
 0.00
OPEN:
0.0011
HIGH:
0.0011
ASK:
0.0000
VOLUME:
0
CHG(%):
1000.00
PREV:
0.0001
LOW:
0.0011
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Sep 250.00110.00110.00110.00110
29 Sep 250.00010.00010.00010.00010
26 Sep 250.00010.00010.00010.0001100
25 Sep 250.00010.00010.00010.0001100
24 Sep 250.00010.00010.00010.0001100
23 Sep 250.00290.00290.00290.0029100
22 Sep 250.00210.00210.00210.0021100
19 Sep 250.05930.05930.05930.0593100
18 Sep 250.05920.05920.05920.0592100
16 Sep 250.05460.05460.05460.0546100

COMPANY PROFILE

Name:KANCERA AB
About:Kancera AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops KAN571, a ROR1 inhibitor for the treatment of mantle cell lymphoma and B-cell malignancy. Kancera AB (publ) was incorporated in 2010 and is headquartered in Solna, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:Karolinska Institutet Science Park, Solna, Sweden, 171 65
Website:https://www.kancera.com
ISIN:SE0015658570

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.00
MA10:0.02
MA20:0.04
MA50:0.07
MA100:0.08
MA200:0.08
STO9:1.69
STO14:1.53
RSI14:23.18
WPR14:-98.47
MTM14:-0.06
ROC14:-0.98
ATR:0.01
Week High:0.00
Week Low:0.00
Month High:0.07
Month Low:0.00
Year High:0.16
Year Low:0.00

RECENT SPLITS

Date Ratio
24 Feb 20211-10